Physician
Lucero, Mariana
Lucero, Mariana was paid $414K by Medicaid between Jan 2018 and Jan 2020, across 23 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 45% of everything it billed.
33Billing provider infoLUCERO, MARIANA
LIBERAL, KS 67901
LIBERAL, KS 67901
33aNPI1831168673assigned 03/15/2006
33bProvider typePediatrics Physician
28Total paid$414K
24GClaims13,893
24DCodes billed23
24AFirst – last monthJan 2018 – Jan 2020
Compared with peers
Next to other Pediatrics Physician providers in Kansas
Rank by total paid#29 of 78
Median peer was paid$136K
This provider vs. median3.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,424 | $313K | |
| 2019 | 3,094 | $93K | |
| 2020 | 375 | $9K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 45% | 4,771 | 4,089 | $185K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 11% | 691 | 615 | $46K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 9.6% | 1,275 | 1,169 | $40K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 7.0% | 427 | 424 | $29K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 6.4% | 1,835 | 891 | $26K |
| 92587 | 5.6% | 527 | 523 | $23K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 4.8% | 2,754 | 2,629 | $20K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 4.3% | 257 | 257 | $18K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.5% | 151 | 150 | $10K |
| D1208 | Topical application of fluoride, excluding varnish | 2.3% | 565 | 562 | $9K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 39 | 38 | $3K |
| 87807 | <1% | 149 | 141 | $2K |
11 more codes
| 99173 | <1% | 299 | $935.00 | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 12 | $619.74 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 21 | $476.16 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 17 | $157.92 |
| 83655 | <1% | 12 | $140.40 | |
| 86318 | <1% | 12 | $110.00 | |
| 81002 | <1% | 26 | $72.24 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 13 | $57.37 |
| 85018 | <1% | 12 | $13.10 | |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | <1% | 12 | $2.42 |
| J7614 | Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg | <1% | 16 | $1.92 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.